Round table conference on tavegyl (HS 592).
D001249:Asthma / Q000188:drug therapy; D002648:Child; D002675:Child, Preschool; D005650:Fumarates / Q000009:adverse effects; D006634:Histamine H1 Antagonists; D006801:Humans; D006967:Hypersensitivity / Q000188:drug therapy; D006255:Rhinitis, Allergic, Seasonal / Q000188:drug therapy; D012871:Skin Diseases / Q000188:drug therapy
D005650:Fumarates; D006634:Histamine H1 Antagonists